Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 22,675 | 16,141 | 8,219 | 1,352 | 454 |
| Operating Income | -22,675 | -16,141 | -8,219 | -1,352 | -454 |
| Interest Expense | 0 | 0 | 1 | 180 | 102 |
| Other Income | 1,017 | 572 | 0 | -22,846 | -574 |
| Pre-tax Income | -21,657 | -15,569 | -8,219 | -24,378 | -1,130 |
| Income Tax | 41 | 26 | 10 | 6 | 18 |
| Net Income Continuous | -21,698 | -15,596 | -8,230 | -24,384 | -1,148 |
| Minority Interests | -85 | -170 | N/A | N/A | N/A |
| Net Income | $-21,613 | $-15,426 | $-8,230 | $-24,384 | $-1,148 |
| EPS Basic Total Ops | -0.76 | -0.89 | -0.59 | -6.64 | -0.34 |
| EPS Basic Continuous Ops | -0.77 | -0.90 | -0.59 | -6.64 | -0.34 |
| EPS Diluted Total Ops | -0.76 | -0.89 | -0.59 | -6.64 | -0.34 |
| EPS Diluted Continuous Ops | -0.77 | -0.90 | -0.59 | -6.64 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.76 | -0.89 | -0.59 | N/A | N/A |
| EBITDA(a) | $-22,559 | $-16,136 | $-8,217 | $-1,291 | $-452 |